agilon health, inc. (AGL)
NYSE: AGL · IEX Real-Time Price · USD
5.88
-0.19 (-3.13%)
Jul 2, 2024, 4:00 PM EDT - Market closed
agilon health Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for agilon health stock have an average target of 8.85, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 50.51% from the current stock price of 5.88.
Analyst Consensus: Hold
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for agilon health stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 1 | 1 | 1 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 6 | 8 | 8 | 9 | 10 | 10 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Initiates $6 | Hold | Initiates | $6 | +2.04% | May 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $6.4 → $6.5 | Hold | Maintains | $6.4 → $6.5 | +10.54% | May 24, 2024 |
| Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +19.05% | May 1, 2024 |
| Citigroup | Citigroup | Hold Initiates $6 | Hold | Initiates | $6 | +2.04% | Apr 22, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $7.5 → $6.4 | Hold | Maintains | $7.5 → $6.4 | +8.84% | Apr 15, 2024 |
Financial Forecast
Revenue This Year
6.22B
from 4.32B
Increased by 44.20%
Revenue Next Year
7.56B
from 6.22B
Increased by 21.43%
EPS This Year
-0.36
from -0.64
EPS Next Year
-0.17
from -0.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.6B | 8.4B | 10.9B | 12.1B | 14.5B |
| Avg | 6.2B | 7.6B | 9.3B | 10.4B | 12.2B |
| Low | 6.0B | 7.0B | 7.8B | 9.0B | 10.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 52.2% | 34.4% | 44.0% | 30.5% | 38.7% |
| Avg | 44.2% | 21.4% | 22.7% | 12.5% | 17.1% |
| Low | 39.3% | 11.7% | 3.0% | -3.4% | -2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.25 | 0.05 | 0.43 |
| Avg | -0.36 | -0.17 | 0.00 |
| Low | -0.47 | -0.25 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.